Ads
-
Related paper
- The use of trypsin-like blood activity as a marker of pulmonary fibrosis severity
- Clinical Characteristics in Combined Pulmonary Fibrosis and Emphysema Syndrome vs Idiopathic Pulmonary Fibrosis Patients
- USE OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR TO IDENTIFY SEVERITY OF LIVER FIBROSIS AND ACTIVITY IN CHRONIC VIRAL HEPATITIS C PATIENTS
- Quantitative determination of trypsin inhibitor as a breeding marker in maize varieties with different resistance to fungal diseases
- Impact of Pulmonary Rehabilitation Program on Ventilatory Functions and Severity Score in Patients with Chronic Obstructive Pulmonary Disease
- NON INVASIVE MARKER (AST/ALT RATIO) TO PREDICT FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE
- Pharmacotherapy in idiopathic pulmonary fibrosis
- A Review of Idiopathic Pulmonary Fibrosis
- Post COVID Pulmonary Fibrosis: What, Why and Whom?
- A Comparative Study on the Antibacterial Activity of Trypsin Inhibitors from the Seeds of Abelmoschus Moschatus L.